The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Dalteparin (Fragmin 2500IU Injection) is an ...
Thiotepa-Based High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Patients With Recurrent or Progressive CNS Germ Cell Tumors Patients with advanced malignancy (N = 385) were randomly assigned ...
Subcutaneous- Unstable angina, Heart Attack- Adult: 120 IU/kg every 12 hour continued for 5-8 days with concomitant low-dose of aspirin. Max: 10,000 IU every 12 hours. The recommended dose is 2500 IU ...
Boston, MA - Results of a randomized study show that the rate of venous thromboembolism (VTE) was halved by prophylaxis with dalteparin, a low-molecular-weight heparin, in patients hospitalized with ...
NEW YORK (MedscapeWire) Nov 30 — Pharmacia Corporation has initiated PREVENT (PRospective EValuation of Dalteparin Efficacy for Prevention of VTE in Immobilized PatieNts Trial) to study the safety and ...
The drug was initially approved by the FDA in 1994 for adults and is a type of heparin. The US Food and Drug Administration has approved Pfizer’s Fragmin (dalteparin sodium) injection to reduce the ...
The US Food and Drug Administration (FDA) approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thromboembolism (VTE) in paediatric ...
Please provide your email address to receive an email when new articles are posted on . Extended treatment with oral edoxaban appeared comparable to subcutaneous dalteparin in safety and effectiveness ...
Please provide your email address to receive an email when new articles are posted on . Treatment of venous thromboembolism with oral apixaban was noninferior to subcutaneous dalteparin, without ...
Thromboembol in blood vessel. Clot formation, 3D illustration Researchers sought to compare oral apixaban and subcutaneous dalteparin for treating patients with cancer-related venous thromboembolism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results